IMVT
Immunovant, Inc. · Healthcare
Chief Legal Officer Tuyl Christopher Van sold $93K of Immunovant, Inc.
Sold$93,217
$35.39Price
2,634Shares
−1%Stake
What IMVT did after the filing
- The stock from Tue, Jun 23 open, $37.36
- +5.1%
- S&P 500, same days
- +4.9%
Measured over 30 trading days, to the Aug 5 close.
Traded Thu, Jun 18. Filed Mon, Jun 22, 4:02 PM ET, after the close. Returns use the Jun 23 open and the Aug 5 close. Not investment advice.